

Most Read This Week
- Adverse Cardiovascular Events and Mortality in Men During Testosterone Treatment
- Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate-Risk Prostate Cancer
- Enzalutamide Active in Low-, Intermediate-Risk Prostate Cancer
- MRI-Guided Focused Ultrasound Focal Therapy for Patients With Intermediate-Risk Prostate Cancer
- SUVmax Determined Using PSMA PET/CT Is Associated With Oncological Outcomes in Patients With Prostate Cancer
Recently Updated
- Enzalutamide Active in Low-, Intermediate-Risk Prostate Cancer
- Rare Germline Variants Are Associated With Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment
- Serum IL-6 as a Prognostic Marker for Response to Intravesical Gemcitabine Therapy in T1 NMIBC
- MRI-Guided Focused Ultrasound Focal Therapy for Patients With Intermediate-Risk Prostate Cancer
- Surveillance After Complete Response to First-Line Chemotherapy in Patients With Metastatic Nonseminomatous Germ Cell Tumor